Title |
Cancer Center Support Grant
|
Institution |
SLOAN-KETTERING INST CAN RESEARCH, NEW YORK, NY
|
Principal Investigator |
THOMPSON, CRAIG
|
NCI Program Director |
THOMPSON
|
Cancer Activity |
Multidisciplinary
|
Division |
OCC
|
Funded Amount |
$55,649
|
Project Dates |
01/20/1997 - 12/31/2018
|
Fiscal Year |
2015
|
Project Type |
Grant
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Aging (3.0%)
Basic Behavioral and Social Science (1.0%)
Behavioral and Social Science (8.0%)
Biochemical Epidemiology (2.0%)
Bone Marrow Transplantation (2.0%)
Cancer (100.0%)
Cancer Survivorship (11.0%)
Chemotherapy (10.0%)
Childhood Cancers (2.0%)
Depression Research (1.0%)
Digestive Diseases (12.0%)
Genetic Testing (1.0%)
Metastasis (22.0%)
Nuclear Magnetic Resonance Imaging (NMR) (3.0%)
Organ Transplantation Research (5.0%)
Smoking Behavior (2.0%)
Surgery (3.0%)
|
Bladder (1.0%)
Brain (6.0%)
Breast (20.0%)
Childhood Leukemia (2.0%)
Colon/Rectum (6.0%)
Head and Neck (2.0%)
Hodgkins disease (1.0%)
Leukemia (15.0%)
Liver Cancer (1.0%)
Lung (7.0%)
Melanoma (6.0%)
Nervous System (1.0%)
Non Hodgkins Lymphoma (4.0%)
Ovarian Cancer (6.0%)
Pancreas (4.0%)
Pituitary (1.0%)
Prostate (9.0%)
Thyroid (3.0%)
Uterine (1.0%)
Sarcoma (1.0%)
|
Research Type |
Cancer Initiation: Alterations in Chromosomes
Resources and Infrastructure Related to Etiology
Resources and Infrastructure Related to Prevention
Resources and Infrastructure Related to Detection, Diagnosis, or Prognosi
Resources and Infrastructure Related to Cancer Control, Survivorship, and Outcomes Researc
|
Abstract |
SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER Memorial Sloan-Kettering Cancer Center (MSKCC) is a free-standing NCI-designated Comprehensive Cancer Research Center dedicated to research and training, with the mission of changing and setting the standards of treatment, prevention and control of cancer through inpatient and outpatient care. MSKCC's research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Molecular Structure); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Survivorship, Outcomes and Risk). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based Investigators and to encourage the application of discoveries in the basic sciences in a way that advances the prevention, detection, diagnosis, and treatment of many forms of cancer. Scientific work in the 10 research programs depends on services provided by 34 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 21 of these core facilities. During the next five years, MSKCC will continue to enlarge its clinical and research facilities and its research and training programs in key research areas. Support is requested to provide developmental funding for the laboratories of new Investigators recruited in research areas aligned with the Center's strategic vision, to support cross-disciplinary pilot projects in population science research, and to support the core facilities." |